What is the address of LAUWERYS RHUMATOLOGIE?

The registered office of LAUWERYS RHUMATOLOGIE is located at Hebronlaan 98, 1950 Kraainem.

Is LAUWERYS RHUMATOLOGIE still active?

Yes. According to the CBE (2 November 2026) LAUWERYS RHUMATOLOGIE is active, legal situation “Normale toestand”, started on 28 May 2021.

Is LAUWERYS RHUMATOLOGIE registered on Peppol?

No, LAUWERYS RHUMATOLOGIE is currently not registered on the Peppol network.

What is the enterprise number of LAUWERYS RHUMATOLOGIE?

The enterprise number of LAUWERYS RHUMATOLOGIE is BE0768872775.

When was LAUWERYS RHUMATOLOGIE founded?

LAUWERYS RHUMATOLOGIE was founded on 28 May 2021.

Who are the directors of LAUWERYS RHUMATOLOGIE?

According to the 2025 annual accounts, the directors of LAUWERYS RHUMATOLOGIE are: Bernard Lauwerys.

Is LAUWERYS RHUMATOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 May 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did LAUWERYS RHUMATOLOGIE make in 2025?

LAUWERYS RHUMATOLOGIE posted a profit after taxes of € 20,850 in financial year 2025.

What is the revenue of LAUWERYS RHUMATOLOGIE?

As a small company, LAUWERYS RHUMATOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 45,656.

LAUWERYS RHUMATOLOGIE (Private Limited) - Kraainem

Dossier LAUWERYS RHUMATOLOGIE, printed on 2 November 2026 from databakkes.be/en/0768872775/lauwerys-rhumatologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

LAUWERYS RHUMATOLOGIE from Kraainem, company number BE0768872775, closed financial year 2025 with a result of € 20,850 after tax. For that financial year LAUWERYS RHUMATOLOGIE recorded a gross margin of € 45,656 and equity of € 23,861. Compared with financial year 2024, the result moved from € 5,656 to € 20,850. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2026.

What it is worth Growing

€ 23,861

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 20,850

▲ 269% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 11,381

▲ 102% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 19,500 paid out

94 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 26,492

▼ 33% vs 2024

Of which on lease € 24,143.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 22,175

▼ 33% vs 2024

€ 3,870 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 1,029

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,896

▲ 77% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 17,390 Gross margin 2022: € 17,390 First fiscal year in the series	€ 19,802 Gross margin 2023: € 19,802 ▲ 14% vs 2022 (€ 17,390) Favourable step	€ 25,763 Gross margin 2024: € 25,763 ▲ 30% vs 2023 (€ 19,802) Favourable step	€ 45,656 Gross margin 2025: € 45,656 ▲ 77% vs 2024 (€ 25,763) Favourable step	▲ 77%
Profit after taxes	€ 10,181 Profit after taxes 2022: € 10,181 First fiscal year in the series	€ 1,633 Profit after taxes 2023: € 1,633 ▼ 84% vs 2022 (€ 10,181) Unfavourable step	€ 5,656 Profit after taxes 2024: € 5,656 ▲ 246% vs 2023 (€ 1,633) Favourable step	€ 20,850 Profit after taxes 2025: € 20,850 ▲ 269% vs 2024 (€ 5,656) Favourable step	▲ 269%
Equity	€ 15,222 Equity 2022: € 15,222 First fiscal year in the series	€ 16,855 Equity 2023: € 16,855 ▲ 11% vs 2022 (€ 15,222) Favourable step	€ 22,511 Equity 2024: € 22,511 ▲ 34% vs 2023 (€ 16,855) Favourable step	€ 23,861 Equity 2025: € 23,861 ▲ 6% vs 2024 (€ 22,511) Favourable step	▲ 6%
Total debts	€ 58,115 Total debts 2022: € 58,115 First fiscal year in the series	€ 45,619 Total debts 2023: € 45,619 ▼ 22% vs 2022 (€ 58,115) Favourable step	€ 37,470 Total debts 2024: € 37,470 ▼ 18% vs 2023 (€ 45,619) Favourable step	€ 31,099 Total debts 2025: € 31,099 ▼ 17% vs 2024 (€ 37,470) Favourable step	▼ 17%
Cash	€ 3,056 Cash 2022: € 3,056 First fiscal year in the series	€ 411 Cash 2023: € 411 ▼ 87% vs 2022 (€ 3,056) Unfavourable step	€ 5,644 Cash 2024: € 5,644 ▲ € 5,233 vs 2023 (€ 411) Favourable step	€ 11,381 Cash 2025: € 11,381 ▲ 102% vs 2024 (€ 5,644) Favourable step	▲ 102%
Retained profit	€ 12,222 Retained profit 2022: € 12,222 First fiscal year in the series	€ 13,855 Retained profit 2023: € 13,855 ▲ 13% vs 2022 (€ 12,222) Favourable step	€ 19,511 Retained profit 2024: € 19,511 ▲ 41% vs 2023 (€ 13,855) Favourable step	€ 20,861 Retained profit 2025: € 20,861 ▲ 7% vs 2024 (€ 19,511) Favourable step	▲ 7%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 19,500 Dividend 2025: € 19,500 Unchanged (€ 0) Unchanged
Bank debt	€ 45,157 Bank debt 2022: € 45,157 First fiscal year in the series	€ 45,157 Bank debt 2023: € 45,157 Unchanged (€ 45,157) Unfavourable step	€ 33,002 Bank debt 2024: € 33,002 ▼ 27% vs 2023 (€ 45,157) Favourable step	€ 22,175 Bank debt 2025: € 22,175 ▼ 33% vs 2024 (€ 33,002) Favourable step	▼ 33%
Balance sheet total	€ 73,338 Balance sheet total 2022: € 73,338 First fiscal year in the series	€ 62,474 Balance sheet total 2023: € 62,474 ▼ 15% vs 2022 (€ 73,338) Unchanged	€ 59,981 Balance sheet total 2024: € 59,981 ▼ 4% vs 2023 (€ 62,474) Unchanged	€ 54,960 Balance sheet total 2025: € 54,960 ▼ 8% vs 2024 (€ 59,981) Unchanged	▼ 8%

Key figures of LAUWERYS RHUMATOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LAUWERYS RHUMATOLOGIE?

What happened at LAUWERYS RHUMATOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 29, 2026 New annual accounts for financial year 2025: profit of € 20,850 (▲ 269% vs 2024). filed late Source: NBB ↗
Jun 1, 2021 Incorporation, published in the Gazette. Source: Staatsblad ↗
May 28, 2021 New establishment in Kraainem. KBO
2021 Bernard Lauwerys became a director. NBB

In short

From € 10,181 profit in 2022 to € 20,850 profit in 2025.

Paid € 15,416 in corporate taxes since 2022.

Best year ever: 2025, with € 20,850 profit.

Paid out € 19,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Bernard Lauwerys

LAUWERYS RHUMATOLOGIE

Behind LAUWERYS RHUMATOLOGIE is Bernard Lauwerys.

Directors

According to the 2025 annual accounts

Bernard Lauwerys

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Hebronlaan 98

1950 Kraainem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

1 June 2021 Source: Deed ↗

LAUWERYS Bernard Robert Jean(comparant (oprichter)) 100%

Details

Company number: 0768.872.775
VAT number: BE 0768.872.775
Registered office: Hebronlaan 98, 1950 Kraainem
Names & denominations: LAUWERYS RHUMATOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 May 2021
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗